American Journal of Neuroradiology, Vol 16, Issue 2 259-264, Copyright © 1995 by American Society of Neuroradiology
ARTICLES |
The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis
MW Tas, F Barkhol, MA van Walderveen, CH Polman, OR Hommes and J Valk
Department of Diagnostic Radiology, Free University Hospital, Amsterdam, The Netherlands.
PURPOSE: To determine whether gadolinium can improve the sensitivity and specificity of MR imaging for the initial diagnosis of multiple sclerosis. METHODS: Patients (n = 57) with neurologic symptoms suggesting multiple sclerosis were studied prospectively. MR imaging consisted of T2-weighted and gadolinium-enhanced T1-weighted spin-echo images. Lumbar puncture was performed for cerebrospinal fluid analysis in 34 patients. RESULTS: After imaging, 17 patients (35%) had clinically definite multiple sclerosis. Cerebrospinal fluid examination had a sensitivity of 69% and specificity of 38%. Using liberal criteria, the sensitivity of T2-weighted MR imaging was 94% and the specificity 55%; using more strict criteria, the specificity increased to 65% with a sensitivity of 88%. Gadopentetate dimeglumine enhancement increased the specificity further to 80% with a loss of sensitivity (59%). CONCLUSION: Gadolinium enhancement increases the specificity of MR imaging in the early diagnosis of multiple sclerosis.
This article has been cited by other articles:
![]() |
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al. A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis Arch Neurol, May 1, 2009; 66(5): 587 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Scozzafava, H. Block, N. Asdaghi, and Z. A. Siddiqi Teaching NeuroImage: Cryptococcal brain pseudocysts in an immunocompetent patient Neurology, August 28, 2007; 69(9): E6 - E7. [Full Text] [PDF] |
||||
![]() |
K. R. Maravilla, J. A. Maldjian, I. M. Schmalfuss, M. J. Kuhn, B. C. Bowen, F. J. Wippold II, V. M. Runge, M. V. Knopp, S. Kremer, L. J. Wolansky, et al. Contrast Enhancement of Central Nervous System Lesions: Multicenter Intraindividual Crossover Comparative Study of Two MR Contrast Agents Radiology, August 1, 2006; 240(2): 389 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.H. Simon, D. Li, A. Traboulsee, P.K. Coyle, D.L. Arnold, F. Barkhof, J.A. Frank, R. Grossman, D.W. Paty, E.W. Radue, et al. Standardized MR Imaging Protocol for Multiple Sclerosis: Consortium of MS Centers Consensus Guidelines. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 455 - 461. [Full Text] [PDF] |
||||
![]() |
A. Minneboo, F. Barkhof, C. H. Polman, B. M. J. Uitdehaag, D. L. Knol, and J. A. Castelijns Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis Arch Neurol, February 1, 2004; 61(2): 217 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sardanelli, A. Iozzelli, C. Losacco, A. Murialdo, and M. Filippi Three Subsequent Single Doses of Gadolinium Chelate for Brain MR Imaging in Multiple Sclerosis AJNR Am. J. Neuroradiol., April 1, 2003; 24(4): 658 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
CHAMPS Study Group MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group Neurology, October 8, 2002; 59(7): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gonen, D. M. Moriarty, B. S. Y. Li, J. S. Babb, J. He, J. Listerud, D. Jacobs, C. E. Markowitz, and R. I. Grossman Relapsing-remitting Multiple Sclerosis and Whole-Brain N-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations Radiology, October 1, 2002; 225(1): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
CHAMPS Study Group Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial Multiple Sclerosis, August 1, 2002; 8(4): 330 - 338. [Abstract] [PDF] |
||||
![]() |
D. L. Arnold and P.M. Matthews MRI in the diagnosis and management of multiple sclerosis Neurology, April 23, 2002; 58(90084): S23 - 31. [Abstract] [Full Text] |
||||
![]() |
J. S. Kaiser, R. I. Grossman, M. Polansky, J. K. Udupa, Y. Miki, and S. L. Galetta Magnetization Transfer Histogram Analysis of Monosymptomatic Episodes of Neurologic Dysfunction: Preliminary Findings AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1043 - 1047. [Abstract] [Full Text] |
||||
![]() |
M. Tintoré, A. Rovira, M. J. Martínez, J. Rio, P. Díaz-Villoslada, L. Brieva, C. Borrás, E. Grivé, J. Capellades, and X. Montalban Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 702 - 706. [Abstract] [Full Text] |
||||
![]() |
J. H. Simon, R. P. Kinkel, L. Jacobs, L. Bub, and N. Simonian A Wallerian degeneration pattern in patients at risk for MS Neurology, March 14, 2000; 54(5): 1155 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P Kinkel, J H Simon, and B Baron Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis `prevention' trials Multiple Sclerosis, October 1, 1999; 5(5): 307 - 312. [Abstract] [PDF] |
||||
![]() |
P. A. Brex, J. I. O'Riordan, K. A. Miszkiel, I. F. Moseley, A. J. Thompson, G. T. Plant, and D. H. Miller Multisequence MRI in clinically isolated syndromes and the early development of MS Neurology, October 1, 1999; 53(6): 1184 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fazekas, F. Barkhof, M. Filippi, R. I. Grossman, D. K. B. Li, W. I. McDonald, H. F. McFarland, D. W. Paty, J. H. Simon, J. S. Wolinsky, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis Neurology, August 1, 1999; 53(3): 448 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Fulton, R. I Grossman, L. J Mannon, J. Udupa, and D. L Kolson Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals Multiple Sclerosis, April 1, 1999; 5(2): 74 - 77. [Abstract] [PDF] |
||||
![]() |
J. Breslau, J. G. Jarvik, D. R. Haynor, W. T. Longstreth Jr, D. L. Kent, and K. R. Maravilla MR Contrast Media in Neuroimaging: A Critical Review of the Literature AJNR Am. J. Neuroradiol., April 1, 1999; 20(4): 670 - 675. [Abstract] [Full Text] |
||||
![]() |
J I O'Riordan, N A Losseff, C Phatouros, A J Thompson, I F Moseley, D G MacManus, W I McDonald, and D H Miller Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 353 - 357. [Abstract] [Full Text] [PDF] |
||||





